Tepotinib in Non-Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations. Paik PK, Felip E, Veillon R, Sakai H, et al. N Engl J Med 2020 May 29. doi: 10.1056/NEJMoa2004407.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Paik PK, Felip E, Veillon R, Sakai H, et al. Tepotinib in Non-Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations. N Engl J Med 2020 May 29. doi: 10.1056/NEJMoa2004407.
PMID: 32469185